Skip to main content
Erschienen in: International Journal of Legal Medicine 2/2011

01.03.2011 | Original Article

Buprenorphine and norbuprenorphine findings in hair during constant maintenance dosage

verfasst von: Gisela Skopp, Anja Kniest, Joerg Haisser, Karl Mann, Derik Hermann

Erschienen in: International Journal of Legal Medicine | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

It is still a matter of debate whether a positive correlation between the dose and the amount of drug in the hair exists. Drugs such as buprenorphine (BUP) used under controlled conditions present an opportunity to prove a possible relationship. Due to discrepant findings of BUP/norbuprenorphine (NBUP) ratios in hair, in vitro degradation of both analytes in diluted acid was also investigated. The levels of BUP and NBUP in proximal hair sections from 18 subjects participating in a maintenance program were determined by liquid chromatography/tandem mass spectrometry following incubation with methanol and subsequent liquid/liquid extraction. BUP and NBUP were incubated in diluted hydrochloric acid at 60°C for up to 24 h. The alleged rearrangement products were simultaneously monitored. All hair samples tested positive for BUP (lower limit of detection–0.238 ng/mg hair) and NBUP (0.043–0.961 ng/mg hair). The concentration of NBUP in hair was consistently higher than that of BUP except for a single specimen. Degradation of BUP and NBUP was dependent on time; hydrolysis of NBUP occurred faster than that of BUP. The concentration of BUP and NBUP will be underestimated if analytes are recovered by acidic procedures. NBUP should be monitored in hair samples besides BUP for the sum of both BUP and NBUP may provide an estimate of BUP exposure following long-term administration of the drug.
Literatur
1.
Zurück zum Zitat Boumba VA, Ziavrou KS, Vougiouklakis T (2006) Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. Int J Toxicol 25:143–161PubMedCrossRef Boumba VA, Ziavrou KS, Vougiouklakis T (2006) Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. Int J Toxicol 25:143–161PubMedCrossRef
2.
Zurück zum Zitat Goodwin RS, Wilkins DG, Averin O, Choo RE, Schroeder JR, Jasinski DR et al (2007) Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration. Clin Chem 53:2136–2143PubMedCrossRef Goodwin RS, Wilkins DG, Averin O, Choo RE, Schroeder JR, Jasinski DR et al (2007) Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration. Clin Chem 53:2136–2143PubMedCrossRef
3.
Zurück zum Zitat Oechsler S, Skopp G (2010) An in vitro approach to estimate putative inhibition of buprenorphine and norbuprenorphine glucuronidation. Int J Legal Med 124:187–194PubMedCrossRef Oechsler S, Skopp G (2010) An in vitro approach to estimate putative inhibition of buprenorphine and norbuprenorphine glucuronidation. Int J Legal Med 124:187–194PubMedCrossRef
4.
Zurück zum Zitat Peters FT, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int 165:216–224PubMedCrossRef Peters FT, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int 165:216–224PubMedCrossRef
5.
Zurück zum Zitat Wilkins DG, Valdez AS, Nagasawa PR, Gygi SP, Rollins DE (1998) Incorporation of drugs for the treatment of substance abuse into pigmented and nonpigmented hair. J Pharm Sci 67:435–440CrossRef Wilkins DG, Valdez AS, Nagasawa PR, Gygi SP, Rollins DE (1998) Incorporation of drugs for the treatment of substance abuse into pigmented and nonpigmented hair. J Pharm Sci 67:435–440CrossRef
6.
Zurück zum Zitat Negrusz A, Moore CM, Perry JL (1998) Detection of doxepin and its major metabolite desmethyldoxepin in hair following drug therapy. J Anal Toxicol 22:531–536PubMed Negrusz A, Moore CM, Perry JL (1998) Detection of doxepin and its major metabolite desmethyldoxepin in hair following drug therapy. J Anal Toxicol 22:531–536PubMed
7.
Zurück zum Zitat Xiang P, Sun Q, Shen B, Shen M (2010) Disposition of ketamine and norketamine in hair after a single dose. Int J Legal Med [Epub ahead of print] PMID: 21153031 Xiang P, Sun Q, Shen B, Shen M (2010) Disposition of ketamine and norketamine in hair after a single dose. Int J Legal Med [Epub ahead of print] PMID: 21153031
8.
Zurück zum Zitat Kuhlmann JJ, Lalani S, Magluilo J, Levine B, Darwin WD, Johnson RE et al (1996) Human pharmacokinetics of intravenous, sublingual and buccal buprenorphine. J Anal Toxicol 20:369–378 Kuhlmann JJ, Lalani S, Magluilo J, Levine B, Darwin WD, Johnson RE et al (1996) Human pharmacokinetics of intravenous, sublingual and buccal buprenorphine. J Anal Toxicol 20:369–378
9.
Zurück zum Zitat Yassen A, Kan J, Olofsen E, Suidgeest E, Dahan A, Danhof M (2007) Pharmacokinetic–pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats. J Pharmacol Exp Ther 321:598–607PubMedCrossRef Yassen A, Kan J, Olofsen E, Suidgeest E, Dahan A, Danhof M (2007) Pharmacokinetic–pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats. J Pharmacol Exp Ther 321:598–607PubMedCrossRef
10.
Zurück zum Zitat Cirimele V, Kintz P, Lohner S, Ludes B (2000) Buprenorphine to norbuprenorphine ratio in human hair. J Anal Toxicol 24:448–449 Cirimele V, Kintz P, Lohner S, Ludes B (2000) Buprenorphine to norbuprenorphine ratio in human hair. J Anal Toxicol 24:448–449
11.
Zurück zum Zitat Zhou SF, Liul P, Chowbay B (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 41:89–295PubMedCrossRef Zhou SF, Liul P, Chowbay B (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 41:89–295PubMedCrossRef
12.
Zurück zum Zitat Blom Y, Bondesson U (1985) Analysis of buprenorphine and its N-dealkylated metabolite in plasma and urine by selected-ion monitoring. J Chromatogr 338:89–98PubMedCrossRef Blom Y, Bondesson U (1985) Analysis of buprenorphine and its N-dealkylated metabolite in plasma and urine by selected-ion monitoring. J Chromatogr 338:89–98PubMedCrossRef
13.
Zurück zum Zitat Kintz P, Villain M, Tracqui A, Cirimele V, Ludes B (2003) Buprenorphine in drug-facilitated sexual abuse: a fatal case involving a 14-year-old boy. J Anal Toxicol 27:527–529PubMed Kintz P, Villain M, Tracqui A, Cirimele V, Ludes B (2003) Buprenorphine in drug-facilitated sexual abuse: a fatal case involving a 14-year-old boy. J Anal Toxicol 27:527–529PubMed
14.
Zurück zum Zitat Tracqui A, Kintz P, Mangin P (1997) HPLC–MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples. J Forensic Sci 42:111–114PubMed Tracqui A, Kintz P, Mangin P (1997) HPLC–MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples. J Forensic Sci 42:111–114PubMed
15.
Zurück zum Zitat Favretto D, Frison G, Vogliardi S, Ferrara SD (2006) Potentials of ion trap collisional spectrometry for liquid chromatography/electrospray ionization tandem mass spectrometry determination of buprenorphine and nor-buprenorphine in urine, blood and hair samples. Rapid Commun Mass Spectrom 20:1257–1268PubMedCrossRef Favretto D, Frison G, Vogliardi S, Ferrara SD (2006) Potentials of ion trap collisional spectrometry for liquid chromatography/electrospray ionization tandem mass spectrometry determination of buprenorphine and nor-buprenorphine in urine, blood and hair samples. Rapid Commun Mass Spectrom 20:1257–1268PubMedCrossRef
16.
Zurück zum Zitat Borriello R, Gargiulo L, Cassandra P (2008) Buprenorphine and norbuprenorphine determination by GC/MS in putrefied biological samples: evaluation of a buprenorphine related death. Ann Toxicol Anal 20:117–119CrossRef Borriello R, Gargiulo L, Cassandra P (2008) Buprenorphine and norbuprenorphine determination by GC/MS in putrefied biological samples: evaluation of a buprenorphine related death. Ann Toxicol Anal 20:117–119CrossRef
17.
Zurück zum Zitat Vincent F, Bessard J, Vacheron J, Mallaret M, Bessard G (1999) Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography–mass spectrometry. J Anal Toxicol 23:270–279PubMed Vincent F, Bessard J, Vacheron J, Mallaret M, Bessard G (1999) Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography–mass spectrometry. J Anal Toxicol 23:270–279PubMed
18.
Zurück zum Zitat Skopp G, Strohbeck-Kuehner P, Mann K, Hermann D (2007) Deposition of cannabinoids in hair after long-term use of cannabis. Forensic Sci Int 170:46–50PubMedCrossRef Skopp G, Strohbeck-Kuehner P, Mann K, Hermann D (2007) Deposition of cannabinoids in hair after long-term use of cannabis. Forensic Sci Int 170:46–50PubMedCrossRef
19.
Zurück zum Zitat Poetsch L, Eser HP, Skopp G, Moeller MR (1998) Zum Suchtmittelnachweis in Haaren. VII: Untersuchungen bei Methadonpatienten unter konstanter Wirkstoffeinnahme. Rechtsmedizin 8:47–50CrossRef Poetsch L, Eser HP, Skopp G, Moeller MR (1998) Zum Suchtmittelnachweis in Haaren. VII: Untersuchungen bei Methadonpatienten unter konstanter Wirkstoffeinnahme. Rechtsmedizin 8:47–50CrossRef
Metadaten
Titel
Buprenorphine and norbuprenorphine findings in hair during constant maintenance dosage
verfasst von
Gisela Skopp
Anja Kniest
Joerg Haisser
Karl Mann
Derik Hermann
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
International Journal of Legal Medicine / Ausgabe 2/2011
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-011-0555-8

Weitere Artikel der Ausgabe 2/2011

International Journal of Legal Medicine 2/2011 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin